A new study by Hospital for Special Surgery (HSS) Research Institute scientists identifies a mechanism by which SARS-CoV-2 induces the inflammatory response in COVID-19 patient lungs, the so-called “cytokine storm,” that can lead to lasting tissue damage and poor patient outcomes. The Lead Investigator Dr. Franck J. Barrat and Dr. Lionel B. Ivashkiv at HSS worked in collaboration with Drs. Olivier Elemento and Robert E. Schwartz at Weill Cornell Medicine (WCM) on this study, looking at lung tissue samples and bronchoalveolar lavage from COVID-19 patients.
Login Or Register To Read Full Story